Atrial fibrillation - Can HbA1c levels really predict the risk?
| Autor: | Rajlakshmi Das, Pradeep Narayan, Mrinalendu Das, Paramita Auddya Ghorai, Debasis Das, Chandan Mandal, Saibal Roy Chowdhury |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Bypass grafting 030204 cardiovascular system & hematology 03 medical and health sciences Hba1c level 0302 clinical medicine Postoperative Complications Risk Factors Internal medicine Atrial Fibrillation medicine Humans In patient 030212 general & internal medicine Coronary Artery Bypass Retrospective Studies Glycated Hemoglobin business.industry Atrial fibrillation General Medicine medicine.disease medicine.anatomical_structure Treatment Outcome Cardiology Surgery Cardiology and Cardiovascular Medicine business Artery |
| Zdroj: | Asian cardiovascularthoracic annals. 30(2) |
| ISSN: | 1816-5370 |
| Popis: | Background Diabetes is associated with higher mortality and worse post-operative outcomes in patients undergoing coronary artery bypass grafting and HbA1c levels have consistently been reported to be associated with adverse post-operative outcomes. However, the role of HbA1c still remains unclear with regards to the occurrence of atrial fibrillation. Method Data for the patients undergoing off-pump coronary artery bypass grafting was analysed in a retrospective fashion. Patients were divided into–those with HbA1c Results Of the 5259 patients included in the study HbA1c was Conclusions After adjusting for confounders HbA1c levels do not independently predict risk of atrial fibrillation after off-pump coronary artery bypass grafting. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|